<DOC>
	<DOC>NCT02310828</DOC>
	<brief_summary>The purpose of this study is to validate the novel hypothesis that daily use of L-cysteine (AcetiumÂ® capsules) is an effective means to decrease the frequency of (or completely abort) the attacks of cluster headache.</brief_summary>
	<brief_title>The Efficacy of L-cysteine in Prevention of Cluster Headache</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Cluster Headache</mesh_term>
	<criteria>1865 years male/female episodic and chronic cluster headache the subjects should report cluster headache attacks with the frequency from one every second day up to five per day. The individual attacks should last from 15 minutes to 3h. patients who meet the International Classification of Headache Disorders II criteria for medication overuse patients who have taken antipsychotics or antidepressant medications during the previous 3 months patients who abuse alcohol or other drugs potentially fertile and sexually active women who do not practise contraception other acute or chronic pain disorders severe psychiatric disease infections malignancy short life expectancy cardiovascular disease cerebrovascular disease uncontrolled hypertension degenerative central nervous system diseases pregnant and lactating women regular users of Acetium capsules for other indications renal dysfunction or cystinuria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Cluster headache</keyword>
	<keyword>Migrainous neuralgia</keyword>
	<keyword>Horton's headache</keyword>
	<keyword>Histaminic cephalalgia</keyword>
</DOC>